306 related articles for article (PubMed ID: 32445025)
1. The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results.
Feldman AZ; Jennings LJ; Wadhwani NR; Brat DJ; Horbinski CM
Curr Neurol Neurosci Rep; 2020 May; 20(7):23. PubMed ID: 32445025
[TBL] [Abstract][Full Text] [Related]
2. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
Yoda RA; Cimino PJ
Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
[TBL] [Abstract][Full Text] [Related]
3. [Molecular Diagnostic Approaches for Diffuse Gliomas Based on Updated WHO Classification and cIMPACT-NOW Proposals].
Masui K; Komori T
No Shinkei Geka; 2021 May; 49(3):510-519. PubMed ID: 34092556
[TBL] [Abstract][Full Text] [Related]
4. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
Onizuka H; Masui K; Komori T
Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
[TBL] [Abstract][Full Text] [Related]
5. [The 2021 WHO classification of tumours of the central nervous system].
Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
[TBL] [Abstract][Full Text] [Related]
6. Adult Diffuse Astrocytic and Oligodendroglial Tumors.
Gestrich CK; Couce ME; Cohen ML
Neurosurgery; 2021 Oct; 89(5):737-749. PubMed ID: 33611566
[TBL] [Abstract][Full Text] [Related]
7. [Classification of gliomas. Current progress and perspectives].
Capper D; Reifenberger G
Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
[TBL] [Abstract][Full Text] [Related]
8. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
9. [The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].
Komori T
Brain Nerve; 2022 Jun; 74(6):803-809. PubMed ID: 35676215
[TBL] [Abstract][Full Text] [Related]
10. The 2016 WHO classification of central nervous system tumors: what neurologists need to know.
DeWitt JC; Mock A; Louis DN
Curr Opin Neurol; 2017 Dec; 30(6):643-649. PubMed ID: 28901970
[TBL] [Abstract][Full Text] [Related]
11. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
12. Integrated dia-gnostics of diffuse gliomas.
Hendrych M; Valeková H; Kazda T; Lakomý R; Šána J; Jančálek R; Slabý O; Hermanová M
Klin Onkol; 2020; 33(4):248-259. PubMed ID: 32894953
[TBL] [Abstract][Full Text] [Related]
13. 2021 World Health Organization Classification of Brain Tumors.
Meredith DM; Pisapia DJ
Continuum (Minneap Minn); 2023 Dec; 29(6):1638-1661. PubMed ID: 38085892
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment.
Funakoshi Y; Hata N; Kuga D; Hatae R; Sangatsuda Y; Fujioka Y; Takigawa K; Mizoguchi M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673070
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors.
Hayashi T; Tateishi K; Matsuyama S; Iwashita H; Miyake Y; Oshima A; Honma H; Sasame J; Takabayashi K; Sugino K; Hirata E; Udaka N; Matsushita Y; Kato I; Hayashi H; Nakamura T; Ikegaya N; Takayama Y; Sonoda M; Oka C; Sato M; Isoda M; Kato M; Uchiyama K; Tanaka T; Muramatsu T; Miyake S; Suzuki R; Takadera M; Tatezuki J; Ayabe J; Suenaga J; Matsunaga S; Miyahara K; Manaka H; Murata H; Yokoyama T; Tanaka Y; Shuto T; Ichimura K; Kato S; Yamanaka S; Cahill DP; Fujii S; Shankar GM; Yamamoto T
Clin Cancer Res; 2024 Jan; 30(1):116-126. PubMed ID: 37851071
[TBL] [Abstract][Full Text] [Related]
16. Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.
Lee SC
Arch Pathol Lab Med; 2018 Jul; 142(7):804-814. PubMed ID: 29775073
[TBL] [Abstract][Full Text] [Related]
17. Targeted Next-Generation Sequencing in Molecular Subtyping of Lower-Grade Diffuse Gliomas: Application of the World Health Organization's 2016 Revised Criteria for Central Nervous System Tumors.
Carter JH; McNulty SN; Cimino PJ; Cottrell CE; Heusel JW; Vigh-Conrad KA; Duncavage EJ
J Mol Diagn; 2017 Mar; 19(2):328-337. PubMed ID: 28042970
[TBL] [Abstract][Full Text] [Related]
18. Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5.
Ahmad Z; Rahim S; Abdul-Ghafar J; Chundriger Q; Ud Din N
Int J Gen Med; 2023; 16():107-127. PubMed ID: 36644568
[TBL] [Abstract][Full Text] [Related]
19. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
Perez A; Huse JT
Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
[TBL] [Abstract][Full Text] [Related]
20. [Classification and Diagnostics of Pediatric Brain Tumors].
Kanemura Y
No Shinkei Geka; 2023 Sep; 51(5):778-788. PubMed ID: 37743329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
